=Ab s t r a c t = Facial palsy as the presenting symptom of leukemia is very rare, especially in acute myeloid leukemia. A review of the medical literature identified reports on 8 children with AML who had facial paralysis as the presenting sign. Whole brain irradiation (WBI) has been applied in most cases. We present the cases of 3 such children. Achieving a remission without WBI, the patients underwent stem cell transplantations (SCTs). Two patients remain event-free 52 months and 62 months after allotransplants. Facial palsy was the harbinger of leukemic relapse in one case after autotransplant. This patient is disease-free 59 months after unrelated SCT rescue. Facial palsy persisted in 2 cases. Allogeneic SCT without WBI may be an effective therapy in patients presenting with facial palsy. A brief review of the literature is presented here. ( 
I n t r o d u c t i o n
Facial palsy is not well recognized as a presenting symptom of childhood leukemia, especially in acute myeloid leukemia (AML). A review of the medical literature identified eight children with AML who had facial paralysis as the presenting sign [1] [2] [3] [4] [5] [6] [7] [8] . Most such cases have blast cells in the cerebrospinal fluid (CSF) and are treated with systemic and intrathecal chemotherapy, and whole brain irradiation (WBI) for recovery of facial palsy [9] [10] [11] . This report describes three children with AML who presented with facial palsy but no blast cells found in the CSF.
Following systemic and intrathecal chemotherapy the patients were effectively rescued by allogeneic stem cell transplantations (SCTs), avoiding WBI. Interval from treatment to improvement of facial palsy 
Ca s er e p o r t 1 .Pa t i e n t1

Di s c u s s i o n
Cranial neuropathies, especially of the seventh nerve, occur in children with central nervous system leukemia caused by leukemic infiltration; however, they are extremely rare as the presenting sign of the disease [1] [2] [3] [4] [5] [6] [7] [8] .
Facial palsy in lymphoid malignancies has been reported in the medical literature and in many cases, there is accompanying meningeal involvement 9, 10) . Among 1,895 children with acute lymphoblastic leukemia (ALL) and non-Hodgkins lymphoma (NHL) 45 children had cranial nerve palsy: 22 at diagnosis (9 ALL, 13 NHL). The facial nerve was the most frequently involved (15 of 22 cases) 12) . However, there are only a few reports where children with myeloid leukemia have presented with a facial palsy [1] [2] [3] [4] [5] [6] [7] [8] . A review of the medical literature identified eleven children with AML who had facial paralysis as the presenting sign. These patients are summarized in Table   1 . Six of 11 children did not have blast cells in the CSF. The brain imaging results were reported in 7 patients at the time of diagnosis: 4 patients had findings of mastoidits but others were normal. Acute otomastoiditis subsequent to leukemic infiltration of the temporal bone may be implicated with facial and acoustic nerve paralysis 8) .
However, the clinical findings of facial paralysis were not always associated with radiological findings.
The time from the appearance of facial paralysis to the diagnosis of leukemia varied from 1 day to 1 month. In four cases, idiopathic facial palsy was suggested, and steroid medication was administered in three of them. The steroid therapy might have resulted in a partial remission of facial palsy, thus delaying the diagnosis of leukemia. Recurrent facial palsy was reported in some cases on follow-up 13) . In our Case 3, facial palsy preceded every relapse of the leukemia. The facial palsy usually improved by 1 to 6 months after beginning chemotherapy (Table 1) . One AML patient did not show improvement of facial palsy after radiotherapy, despite a CR of the leukemia in the BM 7) , Thus, long-term remission of leukemia can be obtainable despite incomplete recovery of facial palsy, as shown in our Cases 2 and 3.
In lymphoma and leukemia patients with symptomatic cranial nerve palsy, CNS irradiation has been reported to be effective [9] [10] [11] . Among 28 adult patients (17 ALL, 9 AML, 2 chronic myelocytic leukemia), 14 complete and 8 partial responses were documented following intrathecal (6 patients), or systemic (5 patients) chemotherapy, or both (17 patients) in addition to the radiotherapy of 24 Gy 10) . On the contrary, most AML patients reported in Table 1 (8/11 ) were treated without radiotherapy. For our three patients, AML was effectively treated by the SCT. Sparing radiotherapy to the brain, especially for children is important to prevent the potential long-term sequelae on cognitive and endocrine function, and to reduce the development of secondary malignancies.
In conclusion, facial palsy may be the presenting sign of AML, and also the harbinger of leukemic relapse.
Allogeneic SCT without WBI may be feasible and effective way to treat these rare AML patients presenting with facial 
